GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

BMS-986482   Click here for help

GtoPdb Ligand ID: 14468

Synonyms: BMS986482 | Example 1 [US12331045]
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: BMS-986482 is a CRBN-mediated Ikaros family zinc finger 1-4 (IKZF1-4) molecular glue degrader [2]. It was designed as an immuno-oncology agent [1].
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 8
Hydrogen bond donors 2
Rotatable bonds 3
Topological polar surface area 114.09
Molecular weight 410.4
XLogP -0.06
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC1=CC(=NC(=C1C)N)C2=CC(=C(C=C2)C3=CN(C4CCC(=O)NC4=O)C(=O)O3)F
Isomeric SMILES CC1=CC(=NC(=C1C)N)C2=CC(=C(C=C2)C3=CN(C(=O)O3)C4CCC(=O)NC4=O)F
InChI InChI=1S/C21H19FN4O4/c1-10-7-15(24-19(23)11(10)2)12-3-4-13(14(22)8-12)17-9-26(21(29)30-17)16-5-6-18(27)25-20(16)28/h3-4,7-9,16H,5-6H2,1-2H3,(H2,23,24)(H,25,27,28)
InChI Key PKEKMIKJWMHBLO-UHFFFAOYSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

No information available.
Summary of Clinical Use Click here for help
BMS-986482 was progressed as a clinical candidate for the treatment of advanced solid tumours.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT06697197 A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors Phase 1/Phase 2 Interventional Bristol-Myers Squibb